Effective Use of Industrial Advisory Boards

1997 ◽  
Vol 11 (4) ◽  
pp. 236-238
Author(s):  
Walter W. Buchanan ◽  
Willard D. Bostwick

The Technology Accreditation Commission (TAC) of the US Accreditation Board for Engineering and Technology (ABET) stipulates that each accredited programme must have an industrial advisory committee composed of industrial representatives. However, how do we ensure that these committees contribute significantly to the growth and development of engineering technology programmes as a means of ensuring technical currency of the programme and the maintenance of close liaison with the employing industries?

2015 ◽  
Vol 5 (2) ◽  
pp. 37 ◽  
Author(s):  
Andy M. Connor ◽  
Sangeeta Karmokar ◽  
Chris Whittington

This paper sets out to challenge the common pedagogies found in STEM (Science, Technology, Engineering and Mathematics) education with a particular focus on engineering. The dominant engineering pedagogy remains “chalk and talk”; despite research evidence that demonstrates its ineffectiveness. Such pedagogical approaches do not embrace the possibilities provided by more student-centric approaches and more active learning. The paper argues that there is a potential confusion in engineering education around the role of active learning approaches, and that the adoption of these approaches may be limited as a result of this confusion, combined with a degree of disciplinary egocentrism. The paper presents examples of design, engineering and technology projects that demonstrate the effectiveness of adopting pedagogies and delivery methods more usually attributed to the liberal arts such as studio based learning. The paper concludes with some suggestions about how best to create a fertile environment from which inquiry based learning can emerge as well as a reflection on whether the only real limitation on cultivating such approaches is the disciplinary egocentrism of traditional engineering educators.


Energy Policy ◽  
2018 ◽  
Vol 123 ◽  
pp. 64-71 ◽  
Author(s):  
Kangyin Dong ◽  
Renjin Sun ◽  
Jin Wu ◽  
Gal Hochman

2021 ◽  
Vol 10 (3) ◽  
pp. 122-122
Author(s):  
Charles L Bennett

Biosimilars are biological drug products that are highly similar to reference products in analytic features, pharmacokinetics and pharmacodynamics, immunogenicity, safety and efficacy. Biosimilar epoetin received US Food and Drug Administration (FDA) approval in 2018 [1]. The manufacturer received an FDA non-approval letter in 2017, despite receiving a favourable review by the FDA’s Oncologic Drugs Advisory Committee (ODAC) and an FDA non-approval letter in 2015 for an earlier formulation.


PEDIATRICS ◽  
1984 ◽  
Vol 73 (6) ◽  
pp. 871-873
Author(s):  
LORING G. DALES ◽  
JAMES CHIN

Elsewhere in this issue, Scott et al1 present results of their study which found that the historical criteria developed by the US Public Health Service Immunization Practices Advisory Committee (ACIP) for detecting students who were susceptible to measles performed very poorly in a school measles outbreak. The ACIP criteria designate as susceptible persons born since 1956 who have no documentation of immunization, who have no physician-Venified history of measles infection, who last received measles vaccine before their first birthday, or who were last immunized (at age 12 months or older) before 1968 with measles virus vaccine that could have been either live or inactivated.


Author(s):  
Molly Y. Zhou

The chapter focuses on the concept of race as a learned identity based on lived experiences of the story teller. Her experience carried her through academic learning in two higher learning institutions in the United States in the south. Besides her learning of academic knowledge, her discovery of relationships on race in education was something not expected before her journey to the west in the US. The journey is a process of rediscovery of herself and her search for knowledge. The repositioning of herself in a racially diverse society such as the US sheds light on the complex issues on race, academic learning and issues on the support and structure of academic learning and professional development for marginalized populations in higher learning institutions. The finding revealed the question of what race is: it is not the knowledge that matters the most, it is the process of finding one's self in diversity that speaks louder on one's growth and development professionally and personally. It is the process of discovering one's race that matters.


2021 ◽  
Vol 10 (13) ◽  
pp. 2878
Author(s):  
Piotr Witkowski ◽  
Jon Odorico ◽  
Jordan Pyda ◽  
Roi Anteby ◽  
Robert Stratta ◽  
...  

The Food and Drug Administration (FDA) has been regulating human islets for allotransplantation as a biologic drug in the US. Consequently, the requirement of a biological license application (BLA) approval before clinical use of islet transplantation as a standard of care procedure has stalled the development of the field for the last 20 years. Herein, we provide our commentary to the multiple FDA’s position papers and guidance for industry arguing that BLA requirement has been inappropriately applied to allogeneic islets, which was delivered to the FDA Cellular, Tissue and Gene Therapies Advisory Committee on 15 April 2021. We provided evidence that BLA requirement and drug related regulations are inadequate in reassuring islet product quality and potency as well as patient safety and clinical outcomes. As leaders in the field of transplantation and endocrinology under the “Islets for US Collaborative” designation, we examined the current regulatory status of islet transplantation in the US and identified several anticipated negative consequences of the BLA approval. In our commentary we also offer an alternative pathway for islet transplantation under the regulatory framework for organ transplantation, which would address deficiencies of in current system.


Sign in / Sign up

Export Citation Format

Share Document